Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 72.48

+4.3%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: growthvalue who wrote (2209)	8/20/1998 11:26:00 AM
From: David Bogdanoff	Read Replies (1) of 4676

G: Regarding news from the phase II trials which are expectd to take a year to complete, the only news you could expect before the trial ends, all data collected and analyzed, and finally reported on at some oncology confefence, are routine things like completion of enrollment, and not very many of those. Also remember that phase II does not evaluate efficacy, it is for determining dosage. David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next